Search Within

Philip Wayne Kantoff

Formats
  1. Journal Article (118)
  2. Meeting Abstract (71)
  3. Review (4)
  4. Correspondence (2)
  5. Editorial (2)
  6. Research Letter (1)
Groups
  1. Department of Medicine (198)
  2. Genitourinary Oncology Service (198)
  3. Solid Tumor Oncology Division (198)
  4. Sloan Kettering Institute Postdocs (71)
  5. GSK Faculty (26)
  6. Human Oncology and Pathogenesis Program (23)

More Groups

People
  1. Konrad Stopsack (44)
  2. Goutam Chakraborty (29)
  3. Ying Mazzu (29)
  4. Subhiksha Nandakumar (27)
  5. Michael Morris (26)
  6. Yuki Yoshikawa (23)

More People

Years
  1. 2025 (4)
  2. 2024 (6)
  3. 2023 (3)
  4. 2022 (14)
  5. 2021 (19)
  6. 2020 (34)

More Years

Publications
  1. Journal of Clinical Oncology (57)
  2. Clinical Cancer Research (17)
  3. Cancer Research (16)
  4. Cancer (9)
  5. Cancer Epidemiology Biomarkers and Prevention (8)
  6. European Urology (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (62)
  2. American Association for Cancer Research (46)
  3. Nature Publishing Group (16)
  4. Oxford University Press (11)
  5. Wiley Blackwell (11)
  6. Elsevier Science, Inc. (8)

More Publishers

Results (198)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of prechemotherapy (pCHT) abiraterone (AA) or enzalutamide (E) for metastatic castration-resistant prostate cancer (mCRPC) after androgen deprivation therapy (ADT) + docetaxel (D) or ADT alone for metastatic hormone sensitive prostate cancer (mHSPC) in a hospital-based registry
    Journal Article

    Francini, E.; Gray, K. P.; Evan, C.; Kaymakcalan, M. D.; Shaw, G. K.; Kantoff, P. W.; Taplin, M. E.; Sweeney, C.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Is the evidence sufficient to recommend statins for all men with prostate cancer?
    Journal Article

    Mucci, L. A.; Kantoff, P. W.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Outcomes of prechemotherapy (pCRx) abiraterone acetate (AA) or enzalutamide (E) for metastatic castration-resistant prostate cancer (mCRPC) after ADT + Docetaxel (D) or ADT alone for metastatic hormone sensitive prostate cancer (mHSPC) in a multi-institution hospital-based registry
    Meeting Abstract

    Francini, E.; Yip, S.; Ahmed, N. S.; Li, H.; Ardolino, L.; Evan, C. P.; Kaymakcalan, M.; Shaw, G. K.; Kantoff, P.; Taplin, M. E.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Gene expression profiling of prostate tissue identifies chromatin regulation as a potential link between obesity and lethal prostate cancer
    Journal Article

    Ebot, E. M.; Gerke, T.; Labbé, D. P.; Sinnott, J. A.; Zadra, G.; Rider, J. R.; Tyekucheva, S.; Wilson, K. M.; Kelly, R. S.; Shui, I. M.; more...
    Cancer (2017)

    Fulltext@MSK | Save
  • Metastasis-free survival is a strong surrogate of overall survival in localized prostate cancer
    Journal Article

    Xie, W.; Regan, M. M.; Buyse, M.; Halabi, S.; Kantoff, P. W.; Sartor, O.; Soule, H.; Clarke, N. W.; Collette, L.; Dignam, J. J.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • The impact of statin use on the efficacy of abiraterone acetate in patients with castration-resistant prostate cancer
    Journal Article

    Harshman, L. C.; Werner, L.; Tripathi, A.; Wang, X.; Maughan, B. L.; Antonarakis, E. S.; Nakabayashi, M.; McKay, R.; Pomerantz, M.; Mucci, L. A.; more...
    Prostate (2017)

    Fulltext@MSK | Save
  • The association between germline BRCA2 variants and sensitivity to platinum-based chemotherapy among men with metastatic prostate cancer
    Journal Article

    Pomerantz, M. M.; Spisák, S.; Jia, L.; Cronin, A. M.; Csabai, I.; Ledet, E.; Sartor, A. O.; Rainville, I.; O'Connor, E. P.; Herbert, Z. T.; more...
    Cancer (2017)

    Fulltext@MSK | Save
  • Androgen receptor-mediated downregulation of microRNA-221 and -222 in castration-resistant prostate cancer
    Journal Article

    Gui, B.; Hsieh, C. L.; Kantoff, P. W.; Kibel, A. S.; Jia, L.
    PLoS ONE (2017)

    Fulltext@MSK | Save
  • Mutation detection in patients with advanced cancer by universal sequencing of cancer-related genes in tumor and normal DNA vs guideline-based germline testing
    Journal Article

    Mandelker, D.; Zhang, L.; Kemel, Y.; Stadler, Z. K.; Joseph, V.; Zehir, A.; Pradhan, N.; Arnold, A.; Walsh, M. F.; Li, Y.; more...
    JAMA - Journal of the American Medical Association (2017)

    Fulltext@MSK | Save
  • Association of tissue abiraterone levels and SLCO genotype with intraprostatic steroids and pathologic response in men with high-risk localized prostate cancer
    Journal Article

    Mostaghel, E. A.; Cho, E.; Zhang, A.; Alyamani, M.; Kaipainen, A.; Green, S.; Marck, B. T.; Sharifi, N.; Wright, J. L.; Gulati, R.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save